芪明颗粒联合人工泪液、非甾体消炎药滴眼液治疗对超声乳化手术术后干眼症患者损伤角膜上皮的作用(3)
綜上所述，在超声乳化手术术后出现干眼症的患者使用传统的人工泪液以及非甾体消炎药滴眼液治疗的方法效果一般，且大部分在超声乳化手术术后出现干眼症的患者常伴随着角膜上皮损伤的并发症，这就更加降低了其治疗的作用，而芪明颗粒联合人工泪液、非甾体消炎药滴眼液在治疗超声乳化手术术后出现干眼症伴角膜上皮损伤的患者有着显著的临床疗效。
参考文献
[1]Kim JS，Lee H，Choi S，et al.Assessment of the Tear Film Lipid Layer Thickness after Cataract Surgery[J].Semin Ophthalmol，2016，43(12)：1-6.
[2]邓显峰，朱峰，陈伟，等.2型糖尿病与干眼症的相关性研究及其危险因素分析[J].现代生物医学进展，2016，16(13)：2503-2506.
, 百拇医药
[3]Suárez AC，Suárez MF，Crim N，et al.Effects produced by different types of laser in cornea of Guinea pigs：Identification of a laser capable of producing superficial lesions without leaving scars[J].Arch Soc Esp Oftalmol，2015，90(10)：458-466.
[4]Yu Y，Hua H，Wu M，et al.Evaluation of dry eye after femtosecond laser-assisted cataract surgery[J].J Cataract Refract Surg，2015，41(12)：2614-2623.
[5]Sahu PK，Das GK，Malik A，et al.Dry Eye Following Phacoemulsification Surgery and its Relation to Associated Intraoperative Risk Factors[J].Middle East Afr J Ophthalmol，2015，22(4)：472-477.
, 百拇医药
[6]Park DH，Chung JK，Seo dR，et al.Clinical Effects and Safety of 3% Diquafosol Ophthalmic Solution for Patients With Dry Eye After Cataract Surgery：A Randomized Controlled Trial[J].Am J Ophthalmol，2016，163(25)：122-131.
[7]Mojzis P，Studeny P，Werner L，et al.Late opacification of a hydrophilic acrylic intraocular lens in Europe[J].Eur J Ophthalmol，2016，26(2)：24-26.
[8]Higuchi A，Oonishi E，Kawakita T，et al.Evaluation of treatment for dry eye with 2-hydroxyestradiol using a dry eye rat model[J].Mol Vis，2016，22(25)：446-453.
, http://www.100md.com
[9]White CJ，DiPasquale SA，Byrne ME.Controlled Release of Multiple Therapeutics from Silicone Hydrogel Contact Lenses[J].Optom Vis Sci，2016，93(4)：377-386.
[10]Symes RJ，Forooghian F.Topical difluprednate monotherapy for uveitic macular edema[J].Can J Ophthalmol，2016，51(1)：47-49.
[11]Lee JS，Kim YH，Park YM.The Toxicity of Nonsteroidal Anti-inflammatory Eye Drops against Human Corneal Epithelial Cells in Vitro[J].J Korean Med Sci，2015，30(12)：1856-1864.
, http://www.100md.com
[12]Colligris B，Crooke A，Huete-Toral F，et al.An update on dry eye disease molecular treatment：advances in drug pipelines[J].Expert Opin Pharmacother，2014，15(10)：1371-1390.
[13]Gadaria-Rathod N，Lee KI，Asbell PA.Emerging drugs for the treatment of dry eye disease[J].Expert Opin Emerg Drugs，2013，18(2)：121-136.
[14]Skalicky SE，Petsoglou C，Gurbaxani A，et al.New agents for treating dry eye syndrome[J].Curr Allergy Asthma Rep，2013，13(3)：322-328., http://www.100md.com(赵智华 李科军 赵晓彬 马青敏 贾志旸)
参考文献
[1]Kim JS，Lee H，Choi S，et al.Assessment of the Tear Film Lipid Layer Thickness after Cataract Surgery[J].Semin Ophthalmol，2016，43(12)：1-6.
[2]邓显峰，朱峰，陈伟，等.2型糖尿病与干眼症的相关性研究及其危险因素分析[J].现代生物医学进展，2016，16(13)：2503-2506.
, 百拇医药
[3]Suárez AC，Suárez MF，Crim N，et al.Effects produced by different types of laser in cornea of Guinea pigs：Identification of a laser capable of producing superficial lesions without leaving scars[J].Arch Soc Esp Oftalmol，2015，90(10)：458-466.
[4]Yu Y，Hua H，Wu M，et al.Evaluation of dry eye after femtosecond laser-assisted cataract surgery[J].J Cataract Refract Surg，2015，41(12)：2614-2623.
[5]Sahu PK，Das GK，Malik A，et al.Dry Eye Following Phacoemulsification Surgery and its Relation to Associated Intraoperative Risk Factors[J].Middle East Afr J Ophthalmol，2015，22(4)：472-477.
, 百拇医药
[6]Park DH，Chung JK，Seo dR，et al.Clinical Effects and Safety of 3% Diquafosol Ophthalmic Solution for Patients With Dry Eye After Cataract Surgery：A Randomized Controlled Trial[J].Am J Ophthalmol，2016，163(25)：122-131.
[7]Mojzis P，Studeny P，Werner L，et al.Late opacification of a hydrophilic acrylic intraocular lens in Europe[J].Eur J Ophthalmol，2016，26(2)：24-26.
[8]Higuchi A，Oonishi E，Kawakita T，et al.Evaluation of treatment for dry eye with 2-hydroxyestradiol using a dry eye rat model[J].Mol Vis，2016，22(25)：446-453.
, http://www.100md.com
[9]White CJ，DiPasquale SA，Byrne ME.Controlled Release of Multiple Therapeutics from Silicone Hydrogel Contact Lenses[J].Optom Vis Sci，2016，93(4)：377-386.
[10]Symes RJ，Forooghian F.Topical difluprednate monotherapy for uveitic macular edema[J].Can J Ophthalmol，2016，51(1)：47-49.
[11]Lee JS，Kim YH，Park YM.The Toxicity of Nonsteroidal Anti-inflammatory Eye Drops against Human Corneal Epithelial Cells in Vitro[J].J Korean Med Sci，2015，30(12)：1856-1864.
, http://www.100md.com
[12]Colligris B，Crooke A，Huete-Toral F，et al.An update on dry eye disease molecular treatment：advances in drug pipelines[J].Expert Opin Pharmacother，2014，15(10)：1371-1390.
[13]Gadaria-Rathod N，Lee KI，Asbell PA.Emerging drugs for the treatment of dry eye disease[J].Expert Opin Emerg Drugs，2013，18(2)：121-136.
[14]Skalicky SE，Petsoglou C，Gurbaxani A，et al.New agents for treating dry eye syndrome[J].Curr Allergy Asthma Rep，2013，13(3)：322-328., http://www.100md.com(赵智华 李科军 赵晓彬 马青敏 贾志旸)